Kyle Gano - Chief Business Development Off, Neurocrine Biosciences Inc
As of February 9, 2022
What is Kyle Gano's Net Worth?
The current estimated net worth of Neurocrine Biosciences Inc's Chief Business Development Off, Kyle Gano, is estimated to be about $30.58M . Kyle Gano owns about 111,173 units of Neurocrine Biosciences Inc common stock. In the last 9 years at Neurocrine Biosciences Inc, Kyle Gano has sold an estimated value of $22.02M worth.
What is Kyle Gano's Past Insider Trading?
Kyle Gano's largest purchase order was 28,266 units , worth over $244.78K on January 7, 2022. Kyle Gano's largest sale order was 28,266 units , worth over $3.25M on August 3, 2018. In total, Kyle Gano has made about 40 transactions over 9 years of their time at Neurocrine Biosciences Inc. Kyle Gano usually trades in February, with the busiest year in 2017. The most recent transaction was a sale order of 6,880 units , worth over $554.63K on February 9, 2022.
Kyle Gano
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Kyle Gano's Salary in 2018?
As Chief Business Development Off of Neurocrine Biosciences Inc, Kyle Gano has a total base salary of $403,100 . Kyle Gano received compensation valued at about $4,568,241 in 2018 after becoming Chief Business Development Off. The vast majority of their compensation came in the form of a bonus of $191,473 , option awards of $1,309,024 , stock awards of $2,656,575 , and other compensation of $8,069 .
What is Kyle Gano's' Mailing Address?
- Mailing address is Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
What are Neurocrine Biosciences Inc's Past Insider Trades?
Neurocrine Biosciences Inc's most recent insider trade came on May 11, 2022 by Richard Pops who sold 15,000 units worth $1.14M . In the last 19 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $350.93M and bought an estimated value of $59.47M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer .
NEUROCRINE BIOSCIENCES INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |